Potential Iatrogenic Medial Meniscal Damage During Tibial Plateau Leveling Osteotomy

Objective— To evaluate potential iatrogenic medial meniscal (MM) damage during tibial plateau leveling osteotomy (TPLO) and to establish a safe zone (SZ) for hypodermic needle (HN) identification of the medial aspect of the stifle joint.
Study Design— Prospective cohort.
Animals— Cadaveric canine stifles (n=40).
Methods— HN (20 or 25 G) were inserted through the medial collateral ligament (MCL) of the femorotibial joint and through the SZ insertion points. The medial meniscus was inspected for iatrogenic damage. Statistical comparison of MM damage caused by different needle sizes and insertion sites was performed using Fisher's exact test with significance at P <.05.
Results— Twenty-gauge group: 65% of stifles had minor MM damage with MCL insertion compared with 35% of stifles with SZ insertion ( P =.0049). Severe MM damage occurred in 25% of stifles with MCL insertion compared with 0% of stifles with SZ insertion ( P =.0014). Twenty-five-gauge group: 85% of stifles had minor MM damage with MCL insertion compared with 30% after SZ insertion ( P =.0011); however, no severe MM injury was noted.
Conclusions— HN insertion though the MCL can produce iatrogenic damage to the MM. Use of a 25 G HN and SZ site for insertion reduced the frequency and severity of MM damage.
Clinical Relevance— HN insertion into the medial aspect of the femorotibial joint during TPLO can cause gross iatrogenic MM damage, which may contribute to the incidence and misdiagnosis of latent MM injuries after TPLO.     

Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine

In veterinary drug development procedures, pharmacokinetic (PK) and pharmacodynamic (PD) data have generally been established in separate, parallel studies to assist in the design of dosage schedules for subsequent evaluation in clinical trials. This review introduces the concept of PK/PD modelling, an approach in which PK and PD data are generated in the same study, and used to derive numerical values for PD parameters based on drug plasma concentrations. The PD parameters define the efficacy, potency and slope (sensitivity) of the concentration-effect relationship. It is proposed that the parameters derived from PK/PD modelling may be used as an alternative and preferred approach to dose titration studies for selecting rational dosage regimens (both dose and dosing interval) for further evaluation in clinical trials. In PK/PD modelling, the explicative variable for effect is the plasma concentration profile. The PK/PD approach provides several advantages over dose-titration studies, including determination of a projected dosage regimen by investigation of a single dose, in contrast to dose-ranging studies which by definition require testing of multiple dosage. Implementation of PK/PD modelling in the veterinary drug development process is currently constrained by the limited number of veterinary studies performed to date, and the consequently limited understanding of PK/PD concepts and their absence from regulatory authority guidelines. Nevertheless, PK/PD modelling has major potential for rational dosage regimen determination, as it considers and quantifies the two main sources of interspecies variability (PK and PD). It is therefore applicable to interspecies extrapolation and to multiple species drug development. As well as the currently limited appreciation of PK/PD principles in the veterinary scientific community, a further constraint in implementing PK/PD modelling is the need to validate PK/PD approaches and thereby gain confidence in its value by pharmaceutical companies and regulatory authorities.     

Day-to-Day variation of the urine protein: creatinine ratio in female dogs with stable glomerular proteinuria caused by X-linked hereditary nephropathy

BACKGROUND: Interpretation of serial urine protein:creatinine (UPC) values is confounded by a lack of data regarding random biologic variation of UPC values in dogs with stable glomerular proteinuria. HYPOTHESIS: That there is minimal day-to-day variability in the UPC of dogs with unchanging proteinuria and the number of measurements needed to reliably estimate UPC varies with the magnitude of proteinuria. ANIMALS: Forty-eight heterozygous (carrier) female dogs with X-linked hereditary nephropathy (XLHN) causing stable proteinuria. METHODS: Urine samples were obtained daily by cystocentesis for 3 consecutive days on 183 occasions (549 samples). The UPC was measured for each sample with a single dry-film chemistry auto-analyzer. Data were analyzed retrospectively by a power of the mean model because the variance of UPC values within the 3-day evaluation periods increased as the magnitude of proteinuria increased. RESULTS: To demonstrate a significant difference (P < .05) between serial values in these proteinuric dogs, the UPC must change by at least 35% at high UPC values (near 12) and 80% at low UPC values (near 0.5). One measurement is adequate to reliably estimate the UPC when UPC <4, but 2-5 determinations are necessary at higher UPC values. CONCLUSIONS AND CLINICAL IMPORTANCE: These guidelines for interpretation of serial UPC values in female dogs with XLHN may also be helpful for interpretation of UPC values in dogs with other glomerulopathies.     

Evaluation of hemostatic derangements associated with canine anaphylaxis and the relationship to syndrome severity

Objective

To describe hemostatic derangements associated with canine anaphylaxis and to assess for association with syndrome severity.

Design

Prospective observational study.

Setting

University teaching hospital.

Animals

Twenty-seven client-owned dogs, recruited from November 2018 to January 2022, diagnosed with anaphylaxis of varying severity were included. Study inclusion required presentation <6 hours after initiation of clinical signs, no medications or history of illness within the prior 2 weeks, lack of comorbidities expected to affect hemostasis, and lack of a disease state that could alternatively explain the clinical presentation.

Interventions

Blood samples were collected within the first hour of presentation for CBC, serum biochemistry, prothrombin time (PT), activated partial thromboplastin time (aPTT), and viscoelastic coagulation testing for use with a cartridge-based point-of-care device.

Measurements and main results

Clotting time and clot formation time were prolonged, alpha angle and maximum clot firmness were decreased, PT and aPTT were prolonged, and platelet counts were lower in severe cases compared to mild and moderate cases. There were no differences for any parameter between mild and moderate cases. The presence or absence of abdominal effusion was not associated with hemostatic status.

Conclusions

Global hemostatic derangements consistent with hypocoagulability are a prominent feature of severe anaphylaxis in dogs and should be considered for routine evaluation.     

Digestion of soybean meal proteinin the equine small and large intestine at various levels of intake

Four mature pony geldings weighing an average of 134 kg and fitted with ileal cannulas were used in a 4×4 Latin square experiment to determine the digestibility of soybean meal (SBM) protein in different segments of the equine digestive tract at various levels of protein intake. A complete basal corn-based diet was supplemented with SBM to formulate four diets with increasing crude protein. The diets, labeled A (basal), B, C and D, contained 4.9%, 9.5%, 14% and 16.5% crude protein (as fed), and provided nitrogen, per feeding, at approximately 44.8, 84.3, 123.9 and 146.3 mg/kg of body weight, respectively. Chromic oxide was fed to measure ileal flow and fecal excretion. Digestion and absorption of nitrogen was determined from changes in nitrogen: chromium ratios, and true digestion of nitrogen was computed by regression analysis. True total tract digestion of nitrogen was 95.7%. True digestibility of nitrogen in the small intestine over the range of linearity was 72.2%, while true digestibility of nitrogen reaching the large intestine was 89.8%. These data indicate that the protein in SBM was almost completely digested in the equine digestive tract. Furthermore, approximately 75% of the digestible protein was digested prececally when nitrogen intake was less than approximately 125 mg/kg of body weight per feeding.     

VERTEBRAL OSTEOSCLEROSIS IN A CAT SECONDARY TO RHABDOMYOSARCOMA

A 5–year–old cat was presented for pelvic limb weakness. Sclerosis of the vertebral body of T–10 was visible on thoracic radiographs. A compressive lesion at this area was noted on myelography. A tumor was partially removed at surgery, but the cat was killed because of poor postoperative response. Rhabdomyosarcoma was diagnosed at necropsy, with bone marrow necrosis and myelofibrosis, and new bone proliferation of the body of T–10. Causes of bone necrosis are discussed.     

IMAGE MAGNIFICATION IN DIGITAL FLUOROSCOPY

Image magnification is inherent in radiography. In digital fluoroscopy, the three components of magnification are geometric, electronic and photographic. In this study, the total magnification factor of a digital imaging system was determined by two methods, 1) comparison of measurements of a known object to its image and 2) calculation of geometric, electronic and photographic magnification from the imaging system specifications. Both methods were employed for various focal-film distances, image intensifier tube modes and laser printer formats. Results of these two methods were different due to the detrimental effect of penumbra on image quality with increasing magnification. If a radiographic image is to be used to approximate object size, then a technique should be used that will minimize magnification. In digital fluoroscopy this is achieved with the shortest object-film distance (assuming a fixed focal-object distance), largest image intensifler mode and greatest number of images per sheet of film.